Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosis
Volume: 48, Issue: 3, Pages: 382 - 386
Published: Jun 21, 2019
Paper Details
Title
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosis
Published Date
Jun 21, 2019
Volume
48
Issue
3
Pages
382 - 386
Notes
History